Physician
Obstetrics & Gynecology
Dr. James H. Pickar, MD
|
|
Give Review
James Pickar practices Obstetrics & Gynecology. He studied medicine at University of Miami Miller School of Medicine. University of Miami Miller School of Medicine is ranked 45 in research and 0 in primary care medicine He has 1 awards "Fellow (FACOG)". James H. Pickar, MD is a published doctor. He has 61 papers published. The most current publication "Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995."
Publications
- Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule.
- Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy.
- A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.
- Recent advances help understand and improve the safety of menopausal therapies.
- Selective estrogen receptor modulators (SERMs): A review of clinical data.
- Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.
- Differential effects of menopausal therapies on the endometrium.
- Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data.
- Emerging therapies for postmenopausal vaginal atrophy.
- Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms.
- A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal wo...
- Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression.
- Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.
- Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women.
- Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
- Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women.
- Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy.
- A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause.
- Body composition during treatment with conjugated estrogens with and without medroxyprogesterone acetate: analysis of the women's Health, Osteoporosis, Progestin, Estr...
- Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
- Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women.
- Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early...
- Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results.
- Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium.
- Menopausal symptoms in older women and the effects of treatment with hormone therapy.
- Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
- Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination.
- Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women.
- Drug firm conflicting interests. If only WHI was done well.
- SERMs: progress and future perspectives.
- Climacteric commentaries. Women''s Health Initiative, osteoporosis prescribing and fracture incidence.
- Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
- Coronary heart disease and menopause management: the swinging pendulum of HRT.
- Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety.
- Do journals have a publication bias?
- Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
- Estrogens in postmenopausal women: recent insights.
- Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group.
- Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study G...
- Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The...
- Is bleeding a predictor of endometrial hyperplasia in postmenopausal women receiving hormone replacement therapy? Menopause Study Group (United States, Italy, Netherla...
- Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995.
- Effects of equine oestrogens on markers of vasoactive function in human coronary artery endothelial cells.
- A comparative study of transvaginal uterine ultrasound and endometrial biopsy for evaluating the endometrium of postmenopausal women taking hormone replacement therapy.
- Recent insights into the varying activity of estrogens.
- Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding.
- The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS).
- Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
- Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding.
- Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.
- Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
- Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement ...
- Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
- Amenorrhea frequency with continuous combined hormone replacement therapy: a retrospective analysis. Menopause Study Group.
- The assessment of bleeding patterns in postmenopausal women during continuous combined hormone replacement therapy: a review of methodology and recommendations for rep...
- Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.
- HRT and breast cancer risk: a realistic perspective.
- The endometrium--from estrogens alone to TSECs.
- Estrogen activity and novel tissue selectivity of delta8,9-dehydroestrone sulfate in postmenopausal women.
- Clinical experience with trimegestone as a new progestin in HRT.
Schools
University of Miami School of Medicine
Conditions Treated
- Osteopenia
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACOG)
Education
-
Sinai Hospital of Baltimore -
University of Miami Miller School of Medicine